Covetrus, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Benjamin Wolin
- Full Time Employees
- 4,035
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 7 Custom House St Portland ME United States of America 04101
- IPO Date
- Feb 4, 2019
- CIK
- 0001752836
- Website
- covetrus.com
- Similar Companies
- Business
- Covetrus, Inc. (NASDAQ: CVET) operates as a global leader in animal-health technology and services, providing comprehensive solutions to veterinary practices in the companion animal, equine, and large-animal markets. The company offers practice management software, data-driven applications, client communication tools, prescription management platforms including online ordering, fulfillment, delivery, and compounding services for personalized medications; supply chain distribution of pharmaceuticals, vaccines, surgical products, diagnostic tests, nutritional supplements, equipment, and finished goods pharmacy products; payment processing, workflow automation, hardware support, credit card services, shipping, manufacturer incentives, and data integration. Covetrus serves over 100,000 veterinary practices worldwide, primarily in North America, Europe, and Asia-Pacific, with target customers including independent clinics, animal-health providers, and pet owners through multi-channel engagement. Founded in 2018 through the merger of Henry Schein's animal health spin-off and Vets First Choice, headquartered in Portland, Maine, the company went public on Nasdaq under CVET in 2019 before being taken private in October 2022 by affiliates of Clayton, Dubilier & Rice (CD&R) and TPG Capital in a $4 billion enterprise value transaction. Recent developments include the September 2025 announcement that its VetSuite platform drove over $30 million in savings for U.S. independent practices; the launch of vRxPro, a next-generation online prescription management solution; the opening of a new state-of-the-art distribution center in Grimes, Iowa; and an expanded pharmaceutical compounding facility in the Phoenix, Arizona area to meet growing demand.
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal
Covetrus and MWI Animal Health to Merge
Covetrus Announces Agreement for Chewy to Acquire SmartEquine
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
CD&R, TPG Take Covetrus Private In $4B Deal
Covetrus going private in $4 billion deal
Covetrus to Be Taken Private for $4 Billion
Covetrus Gets Private-Equity Buyout Offer at $21 a Share
Covetrus (CVET) Q1 Earnings Surpass Estimates
Covetrus Announces First Quarter 2022 Earnings Release Date and Conference Call Information
Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript
Covetrus (CVET) Q4 Earnings Surpass Estimates
Covetrus Announces Financial Results for Fourth Quarter and Full-Year of 2021
Covetrus (CVET) Matches Q3 Earnings Estimates
Covetrus: Q3 Earnings Insights
Covetrus Announces Third Quarter 2021 Earnings Release Date and Conference Call Information
Covetrus Announces Third Quarter 2021 Earnings Release Date and Conference Call Information
Covetrus, Inc. (CVET) CEO Ben Wolin on Q2 2021 Results - Earnings Call Transcript
Covetrus (CVET) Reports Q2 Loss, Tops Revenue Estimates
Covetrus Announces Second Quarter 2021 Earnings Release Date and Conference Call Information